Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP4 | P27487 | 4/20 | 0.68 |
| ▸ | ANPEP | P15144 | 2/20 | 0.68 |
| ▸ | CRHBP | P24387 | 1/20 | 0.60 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.60 |
| ▸ | NR1H3 | Q13133 | 4/20 | 0.50 |
| ▸ | NR1H2 | P55055 | 3/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.46 |
| ▸ | MEN1 | O00255 | 2/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.46 |
| ▸ | RAB9A | P51151 | 1/20 | 0.46 |
| ▸ | MGLL | Q99685 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 2/20 | 0.45 |
| ▸ | MAPT | P10636 | 1/20 | 0.45 |
| ▸ | HTT | P42858 | 1/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.45 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | NPEPPS | P55786 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29382376 | 1.00 | DPP4 (0.68) | DPP4ANPEPCRHBPCRHR2NR1H3 | |
| SCHEMBL29381488 | 0.89 | DPP4 (0.56) | DPP4ANPEPCRHBPCRHR2NR1H3 | |
| SCHEMBL22221562 | 0.86 | ANPEP (0.66) | DPP4ANPEPCRHBPCRHR2KMT2A | |
| SCHEMBL30123663 | 0.85 | ANPEP (0.60) | DPP4ANPEPCRHBPCRHR2KMT2A | |
| SCHEMBL29382416 | 0.85 | DPP4 (0.61) | DPP4ANPEPCRHBPCRHR2NR1H3 | |
| SCHEMBL11600942 | 0.84 | DPP4 (0.55) | DPP4ANPEPCRHBPCRHR2NR1H3 | |
| SCHEMBL11600949 | 0.84 | DPP4 (0.55) | DPP4ANPEPCRHBPCRHR2NR1H3 | |
| SCHEMBL11018579 | 0.83 | DPP4 (0.70) | DPP4ANPEPCRHBPCRHR2KMT2A | |
| SCHEMBL11018633 | 0.83 | DPP4 (0.70) | DPP4ANPEPCRHBPCRHR2 | |
| SCHEMBL987786 | 0.83 | ANPEP (0.70) | DPP4ANPEPCRHBPCRHR2RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 49 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250113829-A1 | HIGH MOLECULAR WEIGHT MODIFIED RNA COMPOSITIONS | nanoSUR LLC | 2025-04-10 | — | — | US | disclosed |
| CN-117466799-B | N-substituted phthalic acid diamide preparation method of imine compound | 西北师范大学 | 2024-12-24 | — | — | CN | disclosed |
| EP-4396348-A2 | HIGH MOLECULAR WEIGHT MODIFIED DSRNA COMPOSITIONS | Nanosur LLC (US) | 2024-07-10 | — | — | EP | disclosed |
| CN-118302524-A | High molecular weight modified dsRNA compositions | 纳诺索尔公司 | 2024-07-05 | — | — | CN | disclosed |
| CN-117466799-A | Preparation method of N-substituted phthalimide compound | 西北师范大学 | 2024-01-30 | — | — | CN | disclosed |
| WO-2023034849-A2 | HIGH MOLECULAR WEIGHT MODIFIED dsRNA COMPOSITIONS | nanoSUR LLC (US) | 2023-03-09 | — | — | WO | disclosed |
| US-11174480-B2 | Post-transcriptionally chemically modified double strand RNAs | nanoSUR LLC (US) | 2021-11-16 | — | — | US | disclosed |
| CN-108291055-B | Sulfur-containing compounds as solvents | 诺华丝国际股份有限公司 | 2021-07-06 | — | — | CN | disclosed |
| CN-112707851-A | Sulfur-containing compounds as solvents | 诺华丝国际股份有限公司 | 2021-04-27 | — | — | CN | disclosed |
| US-10640769-B2 | Post-transcriptionally chemically modified double strand RNAs | nanoSUR LLC (US) | 2020-05-05 | — | — | US | disclosed |
| EP-0245989-B1 | FLUOROPHTHALIMIDES | MEIJI SEIKA KABUSHIKI KAISHA (JP) | 1991-07-10 | — | — | EP | disclosed |
| US-4839378-A | FOR CONTROLLING PLANT DISEASES | MEIJI SEIKA KABUSHIKI KAISHA (JP) | 1989-06-13 | — | — | US | disclosed |
| EP-0306222-A2 | Benzenesulfonanilide derivatives and fungicides for agriculture and horticulture | HOKKO CHEMICAL INDUSTRY CO., LTD (JP) | 1989-03-08 | — | — | EP | disclosed |
| EP-0245989-A2 | Fluorophthalimides | MEIJI SEIKA KABUSHIKI KAISHA (JP) | 1987-11-19 | — | — | EP | disclosed |
| US-4420486-A | Benzoxazolone derivatives, processes for preparation thereof and compositions containing them | HOKKO CHEMICAL INDUSTRY CO., LTD. (JP) | 1983-12-13 | — | — | US | disclosed |
| US-4391804-A | Imidazole derivatives and fungicidal composition containing the same | HOKKO CHEMICAL INDUSTRY COMPANY, LTD. (JP) | 1983-07-05 | — | — | US | disclosed |
| US-4304778-A | 4-Aminoquinazoline derivatives having fungicidal, anti-insect and acaricidal properties | SANKYO COMPANY LIMITED (JP) | 1981-12-08 | — | — | US | disclosed |
| US-4279908-A | Pyridazine derivatives and their use as agricultural fungicides | SANKYO COMPANY LIMITED (JP) | 1981-07-21 | — | — | US | disclosed |
| US-4052395-A | AGRICULTURAL FUNGICIDAL COMPOSITIONS CONTAINING 6-(SUBSTITUTED PHENYL)-PYRIDAZINONES AND SAID PYRIDAZINONES | SANKYO COMPANY LIMITED (JA) | 1977-10-04 | — | — | US | disclosed |
| US-4036631-A | Pyrazolone derivatives and their use as herbicides | SANKYO COMPANY LIMITED (JA) | 1977-07-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250113829-A1 | HIGH MOLECULAR WEIGHT MODIFIED RNA COMPOSITIONS | NSUN2, NSUN3, RNGTT | DPP4 3240/4885ANPEP 2082/4885CRHBP 1276/4885 |
| US-11174480-B2 | Post-transcriptionally chemically modified double strand RNAs | NSUN2, NSUN3, RNGTT | DPP4 4394/4885ANPEP 3641/4885CRHBP 1562/4885 |
| US-10640769-B2 | Post-transcriptionally chemically modified double strand RNAs | NSUN2, NSUN3, RNGTT | DPP4 4394/4885ANPEP 3641/4885CRHBP 1562/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.